What You Need to Know About the Different COVID-19 Vaccines the Philippines May Roll Out
Jan 14, 2021 • Meryl Medel
Nearly a year from the first confirmed case of COVID-19 in the Philippines, talks of procuring vaccines are well underway. Some cities have announced that they have secured a number of supplies for their residents, while the national government has also been in talks with several different suppliers. According to Philippine vaccine czar Carlito Galvez Jr, the government could begin the vaccine distribution as soon as February 2021. But what should you know about the different brands of COVID-19 vaccines that the Philippines may roll out for the public?
[Last updated February 22, 2021, 3:06 p.m.]
AstraZeneca
Patients yesterday from Quinton and Harborne in #Birmingham began receiving their first dose of the AstraZeneca ‘Oxford’ COVID vaccine!
Watch a patient receiving theirs below 👀👇💉#Coronavirus │ #COVID19 pic.twitter.com/xepw6BmcCr
— NHS B’ham & Solihull CCG (@NHSBSolCCG) January 10, 2021
Efficacy rate against COVID-19: 62 to 90%
Where was it developed? United Kingdom
What type of vaccine is it? Viral vector vaccine (which is a vaccine that introduces a modified version of a different harmless virus (called the vector) into our body to teach our cells to recognize the spike protein found only on the surface of the virus and understand that it does not belong inside the body, which then leads to the triggering of our immune system and the production of antibodies)
How many doses are needed? 1 to 2
What is the estimated cost? USD 4/dose, USD 8 per patient (approximately PHP 200/dose, PHP 400/patient)
Which countries have approved it for emergency limited use? United Kingdom, India, Argentina, El Salvador, Mexico, Bangladesh, Dominican Republic
How much supply has the Philippines secured? 13 million doses
Which government units have secured it? Makati, Manila, Quezon City, Valenzuela, Caloocan, Pasig, Las Piñas, Muntinlupa, Navotas, San Juan, Taguig, Baguio, Bacolod, Davao, Dagupan City, Ilocos Norte, Vigan City, Iloilo City, Ormoc City, Zamboanga City, Oroquieta City
Covavax
This morning, we provided an update on clinical development of our #COVID-19 candidate #vaccine, including that we’ve completed enrollment for our pivotal Phase 3 trial in the UK and Phase 2b trial in South Africa. Read our announcement for details. https://t.co/ztcm3U2msz pic.twitter.com/pgeSNbyXwW
— Novavax (@Novavax) November 30, 2020
Efficacy rate against COVID-19: None yet, still in clinical trial stage.
Where was it developed? US-India (Novavax and Serum Institute of India)
What type of vaccine is it? Protein sub-unit vaccine (which is a vaccine that uses purified versions of the virus, as opposed to the whole pathogen, that has lost its disease-producing ability in order to trigger immune response in the body)
How many doses are needed? 2
What is the estimated cost? PHP 366 per patient
Which countries have approved it for emergency limited use? None yet. The vaccine is still in clinical trials in different countries like the United States, the United Kingdom, and Mexico.
How much supply has the Philippines secured? 30 million doses
Sinovac
Efficacy rate against COVID-19: 50 to 78%
Where was it developed? China
What type of vaccine is it? Inactivated vaccine (which is a vaccine that makes use of the killed version of the virus to trigger the immune system and that may require booster shots since it doesn’t provide protection as strong as those from live vaccines)
How many doses are needed? 2
What is the estimated cost? PHP 3,629.50 per patient
Which countries have approved it for emergency limited use? China, Indonesia, Bolivia, and the Philippines, which approved it on February 22, 2021. But because of its lower efficacy rating, FDA Director General Rolando Enrique Domingo says that it is NOT recommended for healthcare workers.
How much supply has the Philippines secured? 25 million doses
Pfizer-BioNTech
Joe Biden receives the second of two doses of the Pfizer COVID-19 vaccine. pic.twitter.com/hO5fTyQslt
— Pat Ward (@WardDPatrick) January 11, 2021
Efficacy rate against COVID-19: 95%
Where was it developed? US-Germany
What type of vaccine is it? RNA-based vaccine (which is a vaccine that uses the genetic material of the virus to provide instructions in making a specific protein from the virus that would then stimulate an immune response in the body)
How many doses are needed? 2
What is the estimated cost? USD 19.50/dose, USD 39 per patient (approximately PHP 937/dose, PHP 1874/patient)
Which countries have approved it for emergency limited use? United Kingdom, United States, Canada, Mexico, European Union, Singapore, Germany, Australia, Kuwait, Israel, Chile, Bahrain, Costa Rica, United Arab Emirates, Qatar, as well as the World Health Organization (WHO)
How much supply has the Philippines secured? A “very sizable amount”
Moderna
Residents of 18 remote First Nations communities in B.C. are among the first people in the province to get the Moderna vaccine. https://t.co/ACHVmetGT7 #covid19 #coronavirus pic.twitter.com/AyeXqeyjmm
— CBC British Columbia (@cbcnewsbc) January 8, 2021
Efficacy rate against COVID-19: 94.5%
Where was it developed? United States
What type of vaccine is it? RNA-based vaccine
How many doses are needed? 2
What is the estimated cost? USD 25/dose, USD 50 per patient (approximately PHP 1,200/dose, PHP 2,400/patient)
Which countries have approved it for emergency limited use? United States, United Kingdom, Canada, Israel
How much supply has the Philippines secured? Still under negotiation.
Janssen
Efficacy rate against COVID-19: None established yet.
Where was it developed? Belgium-US
What type of vaccine is it? Viral vector vaccine
How many doses are needed? 1 to 2
What is the estimated cost? USD 10/dose, USD 20 per patient (approximately PHP 500/dose, PHP 1,000/patient)
Which countries have approved it for emergency limited use? None yet.
How much supply has the Philippines secured? Still under negotiation, but this vaccine is already approved for clinical trials by the FDA.
Clover
Efficacy rate against COVID-19: None yet, still in clinical trial stage.
Where was it developed? China-Australia
What type of vaccine is it? Protein sub-unit vaccine
How many doses are needed? 2
What is the estimated cost? None yet, still in clinical trial stage.
Which countries have approved it for emergency limited use? None yet.
How much supply has the Philippines secured? None so far, but this vaccine is already approved for clinical trials by the FDA.
Gamaleya Institute
Efficacy rate against COVID-19: 91%
Where was it developed? Russia
What type of vaccine is it? Viral vector vaccine
How many doses are needed? 2
What is the estimated cost? PHP 1,220 for two doses
Which countries have approved it for emergency limited use? Russia, Belarus, Argentina
How much supply has the Philippines secured? 25 million doses
What do you think of the different COVID-19 vaccines secured by the Philippines?
1 comment